Works matching IS 00278874 AND DT 2024 AND VI 116 AND IP 9

Results: 20
    1
    2

    Reviewers.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1536, doi. 10.1093/jnci/djae161
    Publication type:
    Article
    3
    4

    Alzheimer disease–related biomarkers and cancer-related cognitive decline: the Thinking and Living with Cancer study.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1495, doi. 10.1093/jnci/djae113
    By:
    • Mandelblatt, Jeanne;
    • Dage, Jeffrey L;
    • Zhou, Xingtao;
    • Small, Brent J;
    • Ahles, Tim A;
    • Ahn, Jaeil;
    • Artese, Ashley;
    • Bethea, Traci N;
    • Breen, Elizabeth C;
    • Carroll, Judith E;
    • Cohen, Harvey J;
    • Extermann, Martine;
    • Graham, Deena;
    • Claudine, Isaacs;
    • Jim, Heather S L;
    • McDonald, Brenna C;
    • Nakamura, Zev M;
    • Patel, Sunita K;
    • Rebeck, G William;
    • Rentscher, Kelly E
    Publication type:
    Article
    5
    6
    7

    Response to Wu and Zhang.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1532, doi. 10.1093/jnci/djae131
    By:
    • Taki, Tetsuro;
    • Ishii, Genichiro
    Publication type:
    Article
    8

    Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208).

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1487, doi. 10.1093/jnci/djae114
    By:
    • Hochster, Howard S;
    • Catalano, Paul;
    • Weitz, Michelle;
    • Mitchell, Edith P;
    • Cohen, Deirdre;
    • O'Dwyer, Peter J;
    • Faller, Bryan A;
    • Kortmansky, Jeremy S;
    • O'Hara, Mark H;
    • Kricher, Sheetal M;
    • Lacy, Jill;
    • Lenz, Heinz-Josef;
    • Verma, Udit;
    • Benson, Al B
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study).

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1439, doi. 10.1093/jnci/djae098
    By:
    • Fontana, Elisa;
    • Rosen, Ezra;
    • Lee, Elizabeth K;
    • Højgaard, Martin;
    • Mettu, Niharika B;
    • Lheureux, Stephanie;
    • Carneiro, Benedito A;
    • Cote, Gregory M;
    • Carter, Louise;
    • Plummer, Ruth;
    • Mahalingam, Devalingam;
    • Fretland, Adrian J;
    • Schonhoft, Joseph D;
    • Silverman, Ian M;
    • Wainszelbaum, Marisa;
    • Xu, Yi;
    • Ulanet, Danielle;
    • Koehler, Maria;
    • Yap, Timothy A
    Publication type:
    Article
    19
    20

    Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1429, doi. 10.1093/jnci/djae095
    By:
    • Keane, Fergus;
    • Chou, Joanne F;
    • Walch, Henry;
    • Schoenfeld, Joshua;
    • Singhal, Anupriya;
    • Cowzer, Darren;
    • Harrold, Emily;
    • O'Connor, Catherine A;
    • Park, Wungki;
    • Varghese, Anna;
    • Dika, Imane El;
    • Balogun, Fiyinfolu;
    • Yu, Kenneth H;
    • Capanu, Marinela;
    • Schultz, Nikolaus;
    • Yaeger, Rona;
    • O'Reilly, Eileen M
    Publication type:
    Article